skip to content

Roche on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020

Roche has hosted a live audio webcast and conference call on Thursday, 6 February 2020.

Live webinar replay

Check out the

Investors

View more Events

Downloads

Presentation

PDF

Related links

Governance
About Roche

Our corporate governance principles focus on sustainable value creation and prescribe a culture that recognises standards of good corporate governance and policy of transparent communication.

Roche’s Annual Report 2019
Investors

How medicines are making an impact in the lives of patients

Product Development Portfolio
Solutions

Discover our pipeline of Pharmaceutical and Diagnostics developments

Frequently Asked Questions
Investors

We answer the Roche investors-related most frequently asked questions